Authors: Marra, FO Frighetto, LO Marra, CA Sleigh, KM Stiver, HG Bryce, EA Reynolds, RP Jewesson, PJ

Citation: Fo. Marra et al., Cost-minimization analysis of piperacillin/tazobactam versus imipenem/cilastatin for the treatment of serious infections: A Canadian hospital perspective, ANN PHARMAC, 33(2), 1999, pp. 156-162